Vasomotor symptoms and depression in women, part 1: Role of vasomotor symptoms in signaling the onset or relapse of a major depressive episode

Journal of Clinical Psychiatry

Volumn 70, Issue 1, 2009, Pages 11-12

  Stahl, Stephen M ^a,b  

^a NEUROSCIENCE EDUCATION INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE; ESTROGEN; NEUROTRANSMITTER;

AMYGDALOID NUCLEUS; CLIMACTERIUM; ESTROGEN BLOOD LEVEL; HUMAN; MAJOR DEPRESSION; PREFRONTAL CORTEX; PRIORITY JOURNAL; RELAPSE; RISK FACTOR; SHORT SURVEY; VASOMOTOR DISORDER; ZONA INCERTA;

AMYGDALA; CLIMACTERIC; DEPRESSIVE DISORDER, MAJOR; ESTROGENS; FEMALE; HOT FLASHES; HUMANS; HYPOTHALAMUS; MIDDLE AGED; NERVE NET; NEUROTRANSMITTER AGENTS; PREFRONTAL CORTEX; RECURRENCE; VASOMOTOR SYSTEM;

EID: 60349083861     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.08bs04900     Document Type: Short Survey

References (6)

1. Stahl SM. Antidepressants. In: Stahl's Essential Psychopharmacology. 3rd ed. New York, NY: Cambridge University Press; 2008:511-666
2. Brizendine L. The Female Brain. New York, NY: Morgan Road Books; 2006
3. Wise DD, Felker A, Stahl SM. Tailoring treatment of depression for women across the reproductive lifecycle: the importance of pregnancy, vasomotor symptoms, and other estrogen-related events in psychopharmacology. CNS Spectrums 2008;13(8):647-662
4. Freeman EW, Sammel MD, Liu L, et al. Hormones and menopausal status as predictors of depression in women in transition to menopause. Arch Gen Psychiatry 2004;61(1):62-70
5. Cohen LS, Soares CN, Vitonis AF, et al. Risk for new onset of depression during the menopausal transition: the Harvard study of moods and cycles. Arch Gen Psychiatry 2006;63(4):385-390
6. Joffe H, Hall JE, Soares CN, et al. Vasomotor symptoms are associated with depression in perimenopausal women seeking primary care. Menopause 2002;9(6):392-398